Increasing Midwifery Students' Awareness of Breast and Gynecological Cancers Using Creative Drama Method
The Effect of Breast and Gynecological Cancer Education Using Creative Drama Method on Midwifery Students' Awareness: A Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2025
CompletedFirst Posted
Study publicly available on registry
July 18, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJuly 18, 2025
July 1, 2025
3 months
July 10, 2025
July 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Personel Information Form
The researcher will prepare a form based on literature information and will question the students' sociodemographic characteristics.
Baseline
Gynecological Cancers Awareness Scale
To assess women's knowledge levels about gynecological cancers, Dal and Ertem developed the Gynecological Cancer Awareness Scale (GCAAS) in 2017. The scale consists of 41 questions and four subscales. 10. The scale can only be applied to women. The Cronbach's alpha value of the scale is 0.944. Questions 20-41 of the scale determine "Awareness of Routine Check-up and Perception of Serious Illness in Gynecological Cancers," and the Cronbach's alpha value of this subscale is 0.979. Questions three through 11 of the scale determine "Awareness of Gynecological Cancer Risks," and the Cronbach's alpha value of this subscale is 0.843. Questions 14-19 of the scale determine "Awareness of Prevention of Gynecological Cancers," and the Cronbach's alpha value is 0.778. The first and second questions of the scale, as well as the 12th and 13th questions, determine "Early Diagnosis and Information Awareness in Gynecological Cancers," and the Cronbach's Alpha value is 0.708.
Baseline and up to 4 weeks
Breast Cancer Awareness Scale
The scale was developed by Rakkapao et al. (2016) for the early detection and prevention of breast cancer. It is easy to use and was designed as a self-report tool that allows researchers and practitioners to better understand women's breast cancer awareness levels. The original scale consists of five factors and 35 items. Adapted to our language by Altuntuğ et al. in 2021, the scale obtained a five-factor structure with 29 items. The subdimensions of the scale were found to have good internal consistency. The Cronbach's alpha internal consistency coefficients for the subdimensions of the scale were 0.87 for Knowledge of Risk Factors, 0.88 for Knowledge of Signs and Symptoms, 0.81 for Breast Cancer Prevention Attitudes, 0.78 for Barriers to Breast Screening, and 0.61 for Health Behavior Related to Breast Cancer Awareness.
Baseline and up to 4 weeks
Study Arms (2)
Control Group
NO INTERVENTIONThe control group will receive routine training and no action will be taken.
Experimental Group
EXPERIMENTALStudents in the intervention group will be given a creative drama session. This will evaluate the impact of creative drama training on breast and gynecological cancer awareness.
Interventions
This study is a pre-test/post-test controlled experimental design aimed at evaluating the effectiveness of creative drama education on awareness of breast and gynecological cancers. Students in the intervention group will receive creative drama-based training structured and implemented by the researcher. This training is designed to increase awareness of breast and gynecological cancers. The effectiveness of the training will be assessed by comparing participants' awareness levels before and after the intervention. For this purpose, the following data collection tools will be used: Personal Information Form Breast Cancer Awareness Scale Gynecological Cancers Awareness Scale The impact of the creative drama education on the awareness levels of students in the intervention group regarding breast and gynecological cancers will be evaluated through statistical analysis.
Eligibility Criteria
You may qualify if:
- Being between the ages of 18-35,
- Not having any health problems,
- Agreeing to participate in the study,
You may not qualify if:
- Students who are under 18 or over 35 years old.
- Students who do not voluntarily agree to participate in the study will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University Faculty of Health Sciences
Erzurum, Center, 25000, Turkey (Türkiye)
Related Publications (1)
Erci B, Karabulut N. Appraising the self-assessed support needs of Turkish women with breast cancer. Eur J Cancer Care (Engl). 2007 Mar;16(2):137-43. doi: 10.1111/j.1365-2354.2006.00721.x.
PMID: 17371422BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Zülbiye DEMİR BARBAK, 1
Ataturk University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
July 10, 2025
First Posted
July 18, 2025
Study Start
August 1, 2025
Primary Completion
November 1, 2025
Study Completion
February 1, 2026
Last Updated
July 18, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share